Table 4.
LVC (g/mL) | LVMi (g/m 2 ) | LVEDVi (mL/m 2 ) | LV E/e'-ratio | LV ejection fraction (%) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
St Beta | R 2 | P -value | St Beta | R 2 | P -value | St Beta | R 2 | P -value | St Beta | R 2 | P -value | St Beta | R 2 | P -value | |
VATi (L/m2) | |||||||||||||||
Model 1 | 0.19 | 0.22 | 0.11 | −0.14 | 0.43 | 0.17 | −0.27 | 0.30 | <0.05 | 0.23 | 0.24 | 0.06 | 0.15 | 0.07 | 0.24 |
Model 2 | 0.11 | 0.23 | 0.54 | −0.03 | 0.46 | 0.85 | −0.10 | 0.33 | 0.53 | 0.05 | 0.26 | 0.81 | 0.15 | 0.08 | 0.42 |
Liver fat (log%) | |||||||||||||||
Model 1 | 0.23 | 0.24 | <0.05 | −0.22 | 0.45 | <0.05 | −0.33 | 0.36 | <0.01 | 0.19 | 0.20 | 0.11 | 0.13 | 0.08 | 0.25 |
Model 2 | 0.13 | 0.23 | 0.33 | −0.23 | 0.46 | <0.05 | −0.27 | 0.33 | <0.05 | 0.12 | 0.26 | 0.42 | 0.06 | 0.08 | 0.69 |
EATi (mL/m2) | |||||||||||||||
Model 1 | 0.07 | 0.20 | 0.51 | −0.04 | 0.41 | 0.63 | −0.12 | 0.29 | 0.24 | 0.24 | 0.22 | <0.05 | 0.02 | 0.07 | 0.88 |
Model 2 | -0.01 | 0.23 | 0.95 | 0.06 | 0.46 | 0.60 | 0.02 | 0.33 | 0.90 | 0.18 | 0.26 | 0.21 | −0.06 | 0.08 | 0.68 |
MFI (%) | |||||||||||||||
Model 1 | 0.20 | 0.27 | 0.13 | 0.03 | 0.44 | 0.76 | −0.14 | 0.37 | 0.25 | 0.22 | 0.20 | 0.12 | 0.05 | 0.08 | 0.72 |
ASATi (L/m2) | |||||||||||||||
Model 1 | 0.19 | 0.21 | 0.13 | −0.18 | 0.43 | 0.10 | −0.30 | 0.30 | <0.05 | 0.34 | 0.29 | <0.01 | 0.20 | 0.07 | 0.14 |
Model 1: included each fat predictor separately plus sex and diabetes. Model 2: included liver fat, VATi and EATi (in the same model) plus sex and diabetes. St Beta, standardized beta coefficient; EATi, epicardial adipose tissue index; ASATi, abdominal subcutaneous adipose tissue index; VATi, visceral adipose tissue index; MFI, thigh muscle fat infiltration; LV, left ventricular; LVC, left ventricular concentricity; LVMi, left ventricular mass index; LVEDVi, left ventricular end-diastolic volume index; E, early diastolic velocity of mitral inflow; e', early diastolic mitral annular velocity.